A Hamster-Derived West Nile Virus Isolate Induces Persistent Renal Infection in Mice

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Saxena, Vandana ^a   Xie, Guorui ^a   Li, Bei ^a   Farris, Tierra ^a   Welte, Thomas ^a   Gong, Bin ^a   Boor, Paul ^a   Wu, Ping ^a   Tang, Shao Jun ^a   Tesh, Robert ^a,b   Wang, Tian ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BETA INTERFERON; CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOLOGY; IMMUNE RESPONSE; KIDNEY DISEASE; LEUKOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS LOAD; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS; ANIMAL; ANIMAL STRUCTURES; BLOOD; C57BL MOUSE; CHRONIC DISEASE; DISEASE MODEL; FEMALE; GENETICS; HAMSTER; ISOLATION AND PURIFICATION; MALE; NEPHRITIS; PATHOGENICITY; PATHOLOGY; SECRETION (PROCESS); VIROLOGY; WEST NILE FEVER;

ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, VIRAL; CHRONIC DISEASE; CRICETINAE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED C57BL; NEPHRITIS; RNA, VIRAL; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84879509279     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002275     Document Type: Article

References (56)

1. Anderson JF, Andreadis TG, Vossbrinck CR, Tirrell S, Wakem EM, et al. (1999) Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 286: 2331-2333.
2. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, et al. (1999) Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333-2337.
3. Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb Mortal Wkly Rep 51: 877-878.
4. Laboratory-acquired West Nile virus infections-United States, 2002. MMWR Morb Mortal Wkly Rep 51: 1133-1135.
5. Alpert SG, Fergerson J, Noel LP, (2003) Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 136: 733-735.
6. Charatan F, (2002) Organ transplants and blood transfusions may transmit West Nile virus. Bmj 325: 566.
7. Gubler DJ, (2007) The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45: 1039-1046.
8. Kramer LD, Styer LM, Ebel GD, (2008) A global perspective on the epidemiology of West Nile virus. Annu Rev Entomol 53: 61-81.
9. Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, et al. (2006) Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 43: 723-730.
10. Ravindra KV, Freifeld AG, Kalil AC, Mercer DF, Grant WJ, et al. (2004) West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis 38: 1257-1260.
11. Ou AC, Ratard RC, (2005) One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana. J La State Med Soc 157: 42-46.
12. Cook RL, Xu X, Yablonsky EJ, Sakata N, Tripp JH, et al. (2010) Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg 83: 1133-1136.
13. Sadek JR, Pergam SA, Harrington JA, Echevarria LA, Davis LE, et al. (2010) Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol 32: 81-87.
14. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, et al. (2008) Virus and antibody dynamics in acute west nile virus infection. J Infect Dis 198: 984-993.
15. Papa A, Danis K, Athanasiadou A, Delianidou M, Panagiotopoulos T, (2011) Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol 83: 1857-1860.
16. Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, et al. (2003) Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis 9: 376-379.
17. Penn RG, Guarner J, Sejvar JJ, Hartman H, McComb RD, et al. (2006) Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis 42: 680-683.
18. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, et al. (2010) Persistent infection with West Nile virus years after initial infection. J Infect Dis 201: 2-4.
19. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, et al. (2010) Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 5: e10649.
20. Pogodina VV, Frolova MP, Malenko GV, Fokina GI, Koreshkova GV, et al. (1983) Study on West Nile virus persistence in monkeys. Arch Virol 75: 71-86.
21. Siddharthan V, Wang H, Motter NE, Hall JO, Skinner RD, et al. (2009) Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. J Virol 83: 4251-4261.
22. Tesh RB, Siirin M, Guzman H, Travassos da Rosa AP, Wu X, et al. (2005) Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 192: 287-295.
23. Tesh RB, Xiao SY (2009) Persistence of West Nile virus infection in vertebrates. In: West Nile Encephalitis Virus Infection Viral Pathogenesis and Host Response, MS Diamond, Ed Springer: New York pp 361-377.
24. Tonry JH, Xiao SY, Siirin M, Chen H, da Rosa AP, et al. (2005) Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg 72: 320-324.
25. Saxena V, Welte T, Bao X, Xie G, Wang J, et al. (2012) A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell lines. Virus Res 167: 179-187.
26. Xiao SY, Guzman H, Zhang H, Travassos da Rosa AP, Tesh RB, (2001) West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 7: 714-721.
27. Wu X, Lu L, Guzman H, Tesh RB, Xiao SY, (2008) Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters. J Gen Virol 89: 3073-3079.
28. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, et al. (2000) Rapid detection of West Nile virus from human clinical specimens, field- collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38: 4066-4071.
29. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, et al. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366-1373.
30. Phares TW, Kean RB, Mikheeva T, Hooper DC, (2006) Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 176: 7666-7675.
31. Sasmono RT, Ehrnsperger A, Cronau SL, Ravasi T, Kandane R, et al. (2007) Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1. J Leukoc Biol 82: 111-123.
32. Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, et al. (2004) Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42: 65-72.
33. Wang S, Welte T, McGargill M, Town T, Thompson J, et al. (2008) Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol 181: 2084-2091.
34. Ascon DB, Ascon M, Satpute S, Lopez-Briones S, Racusen L, et al. (2008) Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol 84: 1400-1409.
35. Brien JD, Uhrlaub JL, Nikolich-Zugich J, (2008) West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 181: 8568-8575.
36. Brien JD, Uhrlaub JL, Nikolich-Zugich J, (2007) Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 37: 1855-1863.
37. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, et al. (2007) Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37: 1845-1854.
38. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M Jr, et al. (2008) Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 82: 8465-8475.
39. Hoey SE, Williams RJ, Perkinton MS, (2009) Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci 29: 4442-4460.
40. Bai F, Town T, Qian F, Wang P, Kamanaka M, et al. (2009) IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 5: e1000610.
41. Samuel MA, Diamond MS, (2005) Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79: 13350-13361.
42. Wang T, Welte T, Saxena V, Xie G (2011) Immunity Versus Immunopathology in West Nile Virus Induced Encephalitis. Flavivirus Encephalitis: Daniel Růžek (Ed.), ISBN: 978-953-307-669-970, InTech.
43. Roehrig JT, Staudinger LA, Hunt AR, Mathews JH, Blair CD, (2001) Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci 951: 286-297.
44. Price WH, Thind IS, (1972) The mechanism of cross-protection afforded by dengue virus against West Nile virus in hamsters. J Hyg (Lond) 70: 611-617.
45. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M, (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578-2586.
46. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, et al. (2003) A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 198: 1853-1862.
47. Shrestha B, Samuel MA, Diamond MS, (2006) CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons. J Virol 80: 119-129.
48. Wang Y, Lobigs M, Lee E, Mullbacher A, (2003) CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77: 13323-13334.
49. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309.
50. Shin H, Wherry EJ, (2007) CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 19: 408-415.
51. Myers L, Messer RJ, Carmody AB, Hasenkrug KJ, (2009) Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads. J Immunol 183: 1636-1643.
52. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, et al. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
53. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, et al. (1996) Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184: 1413-1424.
54. Conti L, Casetti R, Cardone M, Varano B, Martino A, et al. (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174: 252-260.
55. Dieli F, Caccamo N, Meraviglia S, Ivanyi J, Sireci G, et al. (2004) Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response. Eur J Immunol 34: 3227-3235.
56. Shrestha B, Gottlieb D, Diamond MS, (2003) Infection and injury of neurons by West Nile encephalitis virus. J Virol 77: 13203-13213.